News | March 11, 2026
Roche shareholders back full slate of proposals, approve record dividend increase
Dr Severin Schwan was re-elected as Chairman of the Board with 97.75% of the votes
Dr Severin Schwan was re-elected as Chairman of the Board with 97.75% of the votes
Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results
Lupin attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally
200+ HR leaders and CXOs convened to discuss workforce health, preventive care, and organisational wellbeing as strategic business priorities
The new lineup features everything from the Color Fixation and Hair Therapy ranges to the Balanced Cleansing Shampoo and Nourishment & Protection Conditioner
Merck is currently conducting approximately 80 Phase 3 studies, and the company expects more than 20 new growth drivers over next several years, almost all with blockbuster potential
The enhancements will improve environmental sustainability, strengthen material governance, and boost utility reliability
Backed by a multi-hundred-million-dollar investment, the expansion underscores Sanofi’s long-term commitment to India’s thriving life sciences ecosystem
BioAsia 2026 represents a decisive shift toward execution, scale, and global competitiveness, reflecting the rapid evolution of the life sciences ecosystem
The program provides pharmaceutical manufacturers with auditable, primary emissions data and verified proof of a 30% CO? reduction across DFE Pharma’s lactose portfolio
Subscribe To Our Newsletter & Stay Updated
